Zojwalla Naseem 4
4 · Olema Pharmaceuticals, Inc. · Filed Jan 29, 2024
Insider Transaction Report
Form 4
Zojwalla Naseem
CHIEF MEDICAL OFFICER
Transactions
- Exercise/Conversion
Common Stock
2024-01-25$7.02/sh+20,000$140,400→ 66,664 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-01-25−20,000→ 214,000 totalExercise: $7.02Exp: 2032-01-31→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option vested on January 31, 2023 and 1/48 of the total number of shares subject to the option vest each month thereafter, subject to the Reporting Person's continuous service through each applicable vesting date.